SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as retail investors await an imminent phase 3 data readout, fueled by speculation that an upcoming media appearance by the CEO will signal a major milestone or potential buyout. The community remains deeply divided, with bulls pointing to survival data and institutional accumulation as evidence of a breakthrough, while bears cite historical clinical trial failure risks and concerns over trial design.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense volatility and record-breaking trading volume as investors debate whether current levels represent a massive accumulation opportunity or a continued downtrend following recent acquisitions and dilution concerns. The community is heavily focused on the company's defense-tech narrative and upcoming executive meetings, while sentiment remains deeply polarized between those betting on long-term autonomous drone adoption and those skeptical of current execution and management strategy.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is facing significant community polarization as investors debate whether the recent shift to a capped tokenomics model and upgraded infrastructure will trigger a long-term recovery or if the persistent downtrend indicates a failed project. While some holders are actively accumulating to average down, citing institutional interest and upcoming network upgrades, many vocal participants remain skeptical, pointing to lackluster price performance compared to the broader market and aggressive liquidations.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as shareholders speculate on an imminent strategic partnership or buyout, fueled by the founder's recent assertions of international regulatory progress and the potential for disruptive global expansion. Despite concerns over stock volatility, persistent short interest, and the lack of immediate regulatory catalysts, the community remains divided between those expecting a massive, imminent breakthrough in clinical data and others cautioning that revenue growth and label expansions remain a longer-term endeavor.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 is seeing intense community debate as market participants weigh its relative strength against macroeconomic headwinds like geopolitical escalations in the Middle East and cooling inflation data. Traders are actively monitoring small-cap volatility, with many focused on whether current support levels will hold amidst significant uncertainty regarding interest rate policy and broader index rotation.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical (ISRG) is currently facing intense volatility as investors digest a Q2 earnings beat that was overshadowed by a slowdown in U.S. procedure growth and cautious full-year guidance. Despite the stock hitting 52-week lows, the community remains deeply divided, with many long-term holders viewing the pullback as a buying opportunity given the company's dominant market position and cash reserves, while others fear institutional rotation and valuation resets are driving a deeper structural decline.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity is currently trending due to the FDA's recent approval of its lead asset, REVTORPYK, for advanced breast cancer, which serves as a major de-risking milestone and the company's first commercial product. While the stock has faced short-term volatility following the announcement of a Q3 commercial launch delay and profit-taking by major stakeholders, community members are actively debating the potential for long-term growth through future cancer indications and the possibility of a buyout.

Rush Street Interactive, Inc. engages in developing, supplying, and operating regulated online gaming sites. It operates real-money online casino and sports wagering in New Jersey and Pennsylvania and also operates online sports wagering in Indiana, Colorado and Illinois. The company was founded by Neil Gary Bluhm, Gregory A. Carlin, and Richard Schwartz in 2012 and is headquartered in Chicago, IL.

Rush Street Interactive Inc - Ordinary Shares - Class A

Rush Street Interactive is currently trending as investors weigh strong earnings momentum and growth in Latin American markets against broader regulatory concerns surrounding the online gambling and prediction market sector. The community is actively debating the company's valuation relative to its industry peers, with many highlighting its zero-debt balance sheet and record user growth as key drivers for long-term optimism.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is surging as investors speculate on potential positive clinical data and M&A activity, fueled by high trading volume and the company's expanding pipeline for solid tumors. The community is actively discussing the stock's potential for institutional accumulation and a possible short squeeze, as shareholders maintain a long-term bullish outlook regarding upcoming regulatory milestones and pipeline developments.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors closely monitor its heavy AI infrastructure spending and cloud growth momentum ahead of upcoming earnings, while market participants weigh the impact of recent Gemini development delays. Community sentiment remains divided between those viewing the pullback as a buying opportunity in a dominant mega-cap and those concerned that high expectations and valuation could lead to increased volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Industry Outlook Highlights Korn Ferry, ManpowerGroup and Kelly

Staffing firms face near-term industry challenges, but remote work trends and AI-driven hiring tools are helping companies improve efficiency and pursue growth.

Here Are 3 Staffing Stocks to Consider Amid Industry Woes

The Zacks Staffing Firms industry is pressured by the economic setbacks in the manufacturing sector. However, KFY, MAN and KELYA are likely to be at the forefront to witness steady service demand and the increasing adoption of remote work and technology.

KELYA Investors Have Opportunity to Join Kelly Services, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kelly Services, Inc. (Kelly or the Company) (NASDAQ: KELYA) for violations of the securities laws.The investigation focuses on whether the Company issued false...

Kelly Services (KELYA) Q1 Earnings Lag Estimates

Kelly Services (KELYA) delivered earnings and revenue surprises of -59.07% and +2.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Kelly Services (NASDAQ:KELYB) Shares Gap Down - Here's Why

Kelly Services (NASDAQ:KELYB) Shares Gap Down - Here's What Happened...

Insperity, Inc. (NSP) Q1 Earnings and Revenues Top Estimates

Insperity (NSP) delivered earnings and revenue surprises of +5.37% and +0.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Kelly Services (KELYA) Projected to Post Earnings on Thursday

Kelly Services (NASDAQ:KELYA) will be releasing earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-kelly-services-inc-stock...

Kelly Services (NASDAQ:KELYA) Stock Price Passes Above 200-Day Moving Average   - Time to Sell?

Kelly Services (NASDAQ:KELYA) Shares Pass Above Two Hundred Day Moving Average - Should You Sell...

Kelly Services, Inc. (NASDAQ:KELYB) Short Interest Up 765.1% in April

Kelly Services, Inc. (NASDAQ:KELYB - Get Free Report) saw a large growth in short interest in April. As of April 15th, there was short interest totaling 2,656 shares, a growth of 765.1% from the...

Kelly Services (NASDAQ:KELYB) Shares Gap Down - Here's What Happened

Kelly Services (NASDAQ:KELYB) Shares Gap Down - Time to Sell...

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Enterprise Talent Management (ETM), Science, Engineering, and Technology (SET), and Education. The ETM segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The SET segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment is involved in offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

KELYAKelly Services, Inc. - Ordinary Shares - Class A

Fundamentals

Latest KELYA News